Chester County News and Community Website
PHILADELPHIA, PA — This June, as we observe Post-Traumatic Stress Disorder (PTSD) Awareness Month, a convergence of anniversaries provides a solemn opportunity for reflection. In 2025, we will commemorate the …
The Unseen Scars of 250 Years of Service: PTSD and the Opioid Crisis Read More
PHILADELPHIA, PA — Dr. Asif Ilyas, a distinguished surgeon with Rothman Orthopaedics in Philadelphia, has been named to the 2025 Orthopedic Surgery Research All Stars, placing him among the top …
Dr. Asif Ilyas Named to Orthopedic Surgery Research All Stars Top 3% Nationwide by Avant-Garde Health Read More
PHILADELPHIA, PA — The results of a new study suggest patients with chronic pain are turning to medical cannabis to find relief and are also breaking free from traditional painkillers …
Medical Cannabis Reduces Pain and Opioid Pill Use, Preserves Cognition, Study Reveals Read More
PHILADELPHIA, PA — A recent study conducted across nine Iowa hospitals has shown promising results in reducing postoperative opioid prescriptions by implementing Enhanced Recovery After Surgery (ERAS) pathways.
Enhanced Recovery Pathways Slash Opioid Prescriptions Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has commended Nanomerics for the successful completion of a human study utilizing its proprietary Molecular Envelope Technology (MET). The Phase I SUNLIGHT trial …
Virpax Pharmaceuticals Applauds Successful Trial of Molecular Envelope Technology Read More
MALVERN, PA — MAXONA Pharmaceuticals has officially emerged from stealth mode, announcing the successful completion of its U.S. Phase 1 clinical trials for MAX-001, a groundbreaking non-opioid, non-NSAID oral therapy designed …
MAXONA Pharmaceuticals Completes Phase 1 Trials for Breakthrough Pain Therapy Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine) 50 milligram oral tablets, a groundbreaking non-opioid analgesic designed to treat moderate to severe acute pain …
FDA Approves First-in-Class Non-Opioid Pain Drug Journavx Read More BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has reported encouraging results from a minipig Dose Range Finding (DRF) study for Probudur, its long-acting liposomal bupivacaine injection. Designed to provide …
Virpax Pharmaceuticals Announces Positive Results in Study for Long-Lasting Pain Relief Formulation Read More
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has unveiled promising data from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in treating plantar fibromatosis, presented at the American Orthopaedic …
Endo, Inc. Highlights Promising Study Results for Plantar Fibromatosis Treatment Read More
PHILADELPHIA, PA — A recent study has revealed a growing trend among patients with chronic musculoskeletal pain, particularly those with low back pain, turning to medical cannabis for relief. As …
Medical Cannabis Gains Ground as Alternative for Chronic Pain Relief Read More